Tus kws kho mob
QP100-18 Pharmacy Benefit Exclusion for Crinone (progesterone) Gel, Finacea (alzelaic acid) Foam, Glatopa (glatiramer acetate) Injection
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 3171 - 3180 ntawm 3600
Tus kws kho mob
2018 December Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP92-18 Addition of Drug to the Topical Lidocaine Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP96-18 Clarification Regarding the use of PLUTO for Minnesota Health Care Program Subscribers Effective December 1, 2018
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP90-18 Addition of Drugs to the Self-Administered Oncology Agents Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP93-18 Technical Issues with Authorization and Referral Tool on Availity Resolved
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP89-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Circadian Rhythm Disorder
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP91-18 Addition of Drug to the Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP88-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Phenylketonuria
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018